Dr Michael Morris Senior Director of Mass Spectrometry Research Waters Corporation, Wilmslow, England Institution Degree Year Field of study UMIST, Manchester, UK. B.Sc. 1985 Analytical Chemistry UMIST, Manchester, UK. (Michael Barber) Ph.D 1988 Mass Spectrometry Osaka University, Osaka, Japan. (Takekiyo Study leave 1986 Mass spectrometry Matsuo) Purdue University, West Lafayette, USA. Post-doc 1991 Mass spectrometry (Graham Cooks) NRC, Halifax, Canada. (Bob Boyd) Post-doc 1992 Mass spectrometry Dr Morris received his B.Sc. (Hons) in Analytical Chemistry from UMIST, Manchester in 1985, and a Ph.D. in mass spectrometry from the same institution in 1988 under the supervision of the late Professor Michael Barber FRS. He has been involved in a number of research projects, including the ion optic design of sector instruments, development of surface-induced dissociation and the application of tandem mass spectrometry. He spent time working in Japan (Osaka University), USA (Purdue University) and Canada (National Research Council) before joining Micromass/Waters in 1994. Dr Morris founded the Clinical Operations Group in Waters in 1999, and was responsible for the development of applications of mass spectrometry in neonatal screening, therapeutic drug monitoring and clinical toxicology. This technology is now in wide use around the world for routine clinical chemistry analysis. He rejoined the mass spectrometry research team in 2010. Dr Morris has been the co-organiser of a number of national and international meetings and authored more than 50 publications. He is also a Chartered Chemist and Fellow of the Royal Society of Chemistry (C.Chem., F.R.S.C.). In 2012 he was appointed as a visiting Professor in the Department of Surgery and Cancer at Imperial College, London. .